Prof John Hardy News Today

Letters:<strong> Kate Lee</strong> and<em> </em><strong>Prof John T O’Brien </strong>write about the Longitude Prize on Dementia, and <strong>Steve Iliffe </strong>says the benefits of new drugs may be overstated

Lecanemab is the first drug to remove damage, but there are questions around its impact, side effects and use.

Uniindia: London, Nov 30 (UNI) The first drug to slow the destruction of the brain in Alzheimers has been heralded as momentous.